Increased risk of severe infections in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis.

Qing Ma,Li-Yan Gu,Yao-Yao Ren,Li-Li Zeng,Ting Gong,Dian-Sheng Zhong

ONCOTARGETS AND THERAPY（2015）

引用 3|浏览6

暂无评分

摘要

The use of VEGFR-TKIs significantly increases the risk of developing severe and fatal infectious events in cancer patients. A close monitoring for any signs of infections is recommended for patients treated with VEGFR-TKIs.

查看译文

关键词

VEGFR-TKIs,cancer,infections,meta-analysis,randomized controlled trials

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要